Beijing, China
Sinovac Biotech is establishing a five-building vaccine manufacturing campus in Beijing, China. The 32,323-sm project represents an investment of $17.6 million. Housing two production lines, filling and packaging, warehouse space, and a vivarium, the campus will produce vaccines for influenza and enterovirus 71. The facilities will be fully operational in 2012.
